Hypoglycemic Effects of a Dietary Supplement With Inositols, Gymnema Silvestre, Alpha-lactalbumin and Zinc. (EUDIA_22)

Lo.Li.Pharma

Status: Completed

Conditions: Metabolism Disorder

Treatments: Dietary Supplement: EUDIAMET

Study type: Interventional

Funder types: Industry

Identifiers

NCT05348304

EUDIA_22

Details and patient eligibility

About

This study is aimed at evaluating the hypoglycemic effects of a dietary supplement that associates the properties of two inositols (myo-inositol and D-chiro-inositol) in the ratio 40:1 to Gymnema sylvestre, alpha-lactalbumin and zinc.

Enrollment: 37 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• BMI between 30 and 35
• Basal Glycemia between 100 and 125 mg/dl

Exclusion criteria

• Diabetes diagnosis
• Use of food supplements containing inositols, gymnema, alpha-lactalbumin and zinc
• Intolerance to inositols, gymnema, alpha-lactalbumin and zinc

Trial design

Primary purpose: Supportive Care

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

37 participants in 2 patient groups

Control

No Intervention group

Description:

Hypocaloric diet

EUDIAMET

Experimental group

Description:

Hypocaloric diet plus a supplementation with myo-inositol and D-chiro-inositol in the 40:1 ratio, Gymnema sylvestre, alpha-lactalbumin and zinc

Treatment:

Dietary Supplement: EUDIAMET